See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
London Marathon
Pope Francis
Vatican
Social Media
NFL
Real Madrid
Baseball
Catholic Church
Natural Disasters
Donald Trump
Soccer
Published • loading... • Updated

ADA Updates Diabetes Treatment Guidelines to Reelect Benefits of GLP-1

Summary by drugtopics.com
Further, the authors of the “Standards of Care in Diabetes 2025” highlighted the benefits of continuous glucose monitoring systems and recommend initiating these as soon as possible.

2 Articles

All
Left
Center
Right
SpringerSpringer

Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials

We conducted a systematic review and network meta-analysis to compare the efficacy and safety of s.c. administered tirzepatide vs s.c. administered semaglu

·United States
Read Full Article
drugtopics.comdrugtopics.com

ADA Updates Diabetes Treatment Guidelines to Reelect Benefits of GLP-1

Further, the authors of the “Standards of Care in Diabetes 2025” highlighted the benefits of continuous glucose monitoring systems and recommend initiating these as soon as possible.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

drugtopics.com broke the news in on Tuesday, April 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal